Viz.ai Integrates Advanced AI Tools for Enhanced Patient Care
In a significant development for healthcare technology, Viz.ai, a leader in artificial intelligence-driven disease detection, is joining forces with Avicenna.AI. This collaboration aims to integrate Avicenna.AI's CINA-iPE and CINA-ASPECTS tools into the Viz.ai One platform. By doing so, they provide radiologists and other specialists with powerful new insights derived from computed tomography (CT) scans, significantly accelerating and enhancing decision-making in medical care.
A Step Towards Comprehensive Neurovascular Solutions
Justin Ryea, Director of Product at Viz.ai, emphasized the importance of this partnership, stating that it represents an important advancement in their mission. The integration provides a reliable and comprehensive neurovascular solution that doctors can depend on, ensuring that treatment options are explored and patients receive timely care. This partnership builds on the premise of improving workflow and eliminating delays in the assessment of critical conditions.
The Role of CINA-ASPECTS and CINA-iPE
The CINA-ASPECTS tool automates the evaluation of the Alberta Stroke Program Early CT Score from brain images. It helps deliver an objective and evidence-based assessment of stroke severity, a crucial aspect in determining the urgency of intervention. Meanwhile, the CINA-iPE tool is specifically designed to identify incidental pulmonary embolism (PE) during standard CT scans. This capability is vital, as PE can often go undetected; studies show only a fraction of embolisms are reported during initial image readings. With the integration of these tools into Viz.ai One, healthcare providers can communicate in real time, making informed decisions faster about treating patients who may be in crisis.
Enhancing Quality and Efficiency in Medical Imaging
Cyril Di Grandi, the CEO of Avicenna.AI, shared his enthusiasm regarding the partnership, noting that it elevates the standard of care available to patients. The integration of these advanced AI tools aligns seamlessly with their shared vision of equipping healthcare professionals with innovative technology. Such solutions not only expedite the identification of critical health issues but also streamline follow-up care, ensuring patients receive appropriate treatment promptly.
About Viz.ai and Its Innovative Solutions
Founded with the goal of revolutionizing healthcare, Viz.ai has pioneered the use of sophisticated AI algorithms. Their cutting-edge platform is currently utilized by over 1,700 hospitals and health institutions across the globe. The AI-driven Viz.ai One platform plays a vital role in identifying potential health risks, aiding critical decision-making, and improving the overall workflow within healthcare settings. By providing substantial clinical evidence, Viz.ai One aims to enhance the efficiency of patient care and deliver significant benefits to medical professionals and health systems alike.
About Avicenna.AI and Its Expertise in Radiology
Avicenna.AI, founded in 2018, focuses on healthcare AI that leverages high-level machine learning technologies. Co-founded by visionary leaders in the field, who boast extensive experience in the industry, Avicenna.AI specializes in detecting and quantifying serious medical conditions through advanced CT image analysis. Their tools aim to enhance the speed of decision-making in critical scenarios, thereby improving patient outcomes significantly.
Frequently Asked Questions
What is Viz.ai integrating with Avicenna.AI?
Viz.ai is integrating Avicenna.AI's CINA-iPE and CINA-ASPECTS tools into its Viz.ai One platform to enhance stroke assessment and patient care.
What does the CINA-ASPECTS tool do?
The CINA-ASPECTS tool automatically assesses the Alberta Stroke Program Early CT Score from brain images, providing a reliable measure of stroke severity.
Why is the integration of these tools significant?
This integration allows for faster and more informed decision-making in medical care, significantly improving response times in critical scenarios.
Who are the key players involved in this partnership?
The partnership is between Viz.ai, led by Justin Ryea, and Avicenna.AI, co-founded by Cyril Di Grandi and Dr. Peter Chang.
How does this impact patient care?
By integrating advanced AI tools, Viz.ai and Avicenna.AI aim to provide higher quality care and reduce the time taken to diagnose and treat life-threatening conditions.
